Cytoskeletal Protein Variants Driving Atrial Fibrillation: Potential Mechanisms of Action

Area of Science:

• Cardiology
• Genetics
• Molecular Biology

Background:

• Atrial fibrillation (AF) affects 1-2% of the population and is often linked to common risk factors.
• Familial AF accounts for 15% of cases, with genetic variants identified in regulatory elements, ion channels, and cytoskeletal proteins.
• Cytoskeletal protein variants are associated with cardiomyopathy, and AF can be an early sign of cardiac disease.

Purpose of the Study:

• To review cytoskeletal (associated) gene variants implicated in genetic atrial fibrillation (AF).
• To explore potential pathophysiological mechanisms linking cytoskeletal defects to AF.
• To highlight the role of genetic factors in AF development, particularly in familial cases.

Main Methods:

• Review of existing literature on genetic atrial fibrillation (AF).
• Analysis of genome and exome sequencing data identifying genetic variants.
• Examination of studies linking cytoskeletal protein variants to cardiac disease and AF.

Main Results:

• Genome sequencing identified variants in non-coding regions, ion channels, and cytoskeletal genes in familial AF.
• Specific cytoskeletal protein variants (e.g., desmin, lamin A/C, titin) are associated with cardiomyopathy.
• AF onset can precede cardiomyopathy, indicating AF as a potential initial manifestation of genetic cardiac disease.

Conclusions:

• Cytoskeletal protein variants disrupt cardiomyocyte structure and can trigger DNA damage, contributing to AF.
• Genetic factors, particularly cytoskeletal gene variants, play a significant role in the pathogenesis of familial AF.
• Further research into the pathophysiological mechanisms of genetic AF is crucial for understanding and potentially treating the condition.